RayzeBio
San Diego, CA
RayzeBio is focused on improving outcomes for people with cancer by harnessing the power of targeted radioisotopes. As the emerging leader in radiopharmaceuticals, RayzeBio is developing an innovative robust pipeline against validated oncology drug targets to deliver radioisotopes that emit alpha particles such as Actinium-225.
rayzebio.comCompany Details
Founded
- 2020
Employees
- Between 50 - 100 employees
Raised
- $418,000,000
Headquarters Location
- San Diego, CA
Public
- Yes
Acquired
- Yes
CEO
Ken Song
Founders
- Deborah CharychAron Knickerbocker
Company Collections
These are collections RayzeBio is a part of. Click on the collection name to view similar companies.